clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Sui...

FDA Recall #D-0537-2025 — Class II — June 27, 2025

Recall #D-0537-2025 Date: June 27, 2025 Classification: Class II Status: Terminated

Product Description

clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01

Reason for Recall

Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.

Recalling Firm

Lupin Pharmaceuticals Inc. — Naples, FL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,724 bottles

Distribution

Nationwide.

Code Information

Lot # M300464, exp. date June, 2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated